PARP1 and acute myeloid leukemia: For example, poly-ADP-ribose polymerase 1 (PARP1) plays a role in repressing expression of NKG2D ligands on AML cells and PARP inhibitors may be a therapeutic target to increase ligand expression and improve NK cell detection of leukemia stem cells [86].